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also help to address potential safety issues of online 
interventions—ie, how to deal with suicidality or 
other crisis situations. 
The results might have larger implications beyond 
multiple sclerosis because they are likely to apply to 
patients with other chronic disorders and comorbid 
depression. A potential next step is to adjust the 
programme to speciﬁ c needs of patients with a 
disabling medical disorder such as multiple sclerosis. 
It remains to be seen whether these results are 
also applicable to patients with more severe forms 
depression. Online CBT is probably best used in 
stepped-care models of depression treatment. In 
these models, interaction with a psychotherapist and 
pharmacotherapy can be added in case iCBT as a ﬁ rst 
step of treatment does not elicit a suﬃ  cient treatment 
response. 
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The relationship between depression and violent crime
The association between depression and violence has 
been fairly under-studied, especially in comparison 
with schizophrenia, and this has led to inconsistent 
results.1 In The Lancet Psychiatry, Seena Fazel and 
colleagues2 present the results of two separate studies 
in Sweden that examine the association between 
depression and violent oﬀ ences.
The ﬁ rst is a total population study that compared 
patients with depression with general population 
controls matched individually by age and sex. Patients 
with depression were identiﬁ ed from the Swedish 
National Patient Register as having an outpatient 
diagnosis of depression in secondary or tertiary care. 
The data for conviction of violent oﬀ ences were taken 
from the National Crime Register. The mean follow-
up length was roughly 3 years. After adjustment for 
family income and immigrant status, the odds ratio of 
violent crime was 3·0 in comparison with the general 
population.
The second is a cohort study of twins who had 
participated in twin studies in which they had 
answered a self-report depression questionnaire. 
The data for convictions were again taken from the 
National Crime Register. The mean follow-up length 
was about 5 years. The hazard ratio of violent crime 
for a one-point increase in the questionnaire was 1·09, 
which would translate into a hazard ratio of 2·4 for a 
2 SD diﬀ erence.
Despite the many admirable characteristics of the 
Swedish registries used in these studies, registry-based 
studies cannot avoid many ambiguities. The authors, 
however, tackle these weaknesses through ingenious 
study designs and several sensitivity analyses. In the 
ﬁ rst study, they also took unaﬀ ected siblings of the 
cases as controls and still noted an elevated odds 
ratio of 1·5. This means that the association between 
depression and violence is partly due to, but beyond, 
early environmental and genetic factors shared by 
siblings. They were also able to examine the eﬀ ect 
of comorbid substance use or personality disorders, 
previous crimes, types of violent crimes committed, or 
the interval between depression diagnosis and oﬀ ence 
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but identiﬁ ed few diﬀ erences. The second study 
corroborated the ﬁ rst study. There are, however, other 
factors that were not addressed in these studies, such 
as the inﬂ uence of adversities and other unmeasured 
psychosocial factors, eﬀ ects of treatments, or the 
problem of non-treatment-seeking people with 
depression. It must be noted, however, that adjustment 
for covariates in epidemiological studies presents 
diﬃ  culties with interpretation, because diﬀ erent 
studies adjust for diﬀ erent variables, possibly under 
the inﬂ uence of nominal statistical signiﬁ cance. These 
so-called adjusted indexes of association are hard to 
compare and combine.
In interpretation of the ﬁ ndings of this study, it is 
important to place these relative measures in context 
with corresponding ﬁ gures for other mental disorders. 
Fortunately, the same authors have undertaken 
similarly designed studies for schizophrenia,3 bipolar 
disorder,4 traumatic brain injury, and epilepsy.5 The 
adjusted odds ratio of patients versus the general 
population was 7·4 for schizophrenia, 5·8 for bipolar 
disorder, 3·3 for traumatic brain injury, and 1·5 for 
epilepsy (all statistically signiﬁ cant). 
The relative measures of association also have to 
be evaluated in the absolute measures. The incidence 
of violent crime in the cases with depression was 
3·7% (men) and 0·5% (women) during the mean 
follow-up of 3 years compared with 10·7% (men) 
and 2·7% (women) for schizophrenia within 5 years 
of ﬁ rst diagnosis. In patients with bipolar disorder 
the incidence was 9·5%, in patients with traumatic 
brain injury was 8·8%, and in patients with epilepsy 
was 4·2%.
How can we make informed and judicious use of 
these research ﬁ ndings at the individual and societal 
level? In the Discussion, the authors contrast the 
inconsistent recommendations of current clinical 
guidelines for depression regarding risk assessment, 
and emphasise the need for clinicians to identify high 
risk groups. At the individual level, it is important to 
note that risk assessment for rare events is bound 
to have high false positive rates.6 Even if we had 
a screening assessment that had a sensitivity and 
speciﬁ city of 80% each, if the event rate is 10%, the 
positive predictive value is only around 30%. In other 
words, seven of ten so-called positive or high risk 
cases would not have the event. At the societal level, 
we must pay due caution to the stigma of violence in 
mental health. As the authors suggest, investigation 
of pharmacological or psychosocial interventions to 
reduce violence among high-risk groups would be 
most welcome.
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